Table 2.
Treatment Groups | GPx (µM/mg protein) | Catalase (mM/mg protein) | SOD (U/mg protein) | Total GSH (nM/mg protein) |
---|---|---|---|---|
Control | 1.62 ± 0.02 | 0.080 ± 0.01* | 5.99 ± 1.17* | 6.43 ± 0.25* |
CTN 100 µm | 0.87 ± 0.01 | 0.038 ± 0.01* | 1.81 ± 0.40* | 2.81 ± 0.33* |
GTE 20 µg/ml + CTN | 0.94 ± 0.01 | 0.038 ± 0.01 | 3.02 ± 0.28 | 2.84 ± 0.53 |
GTE 40 µg/ml + CTN | 0.94 ± 0.01 | 0.064 ± 0.01# | 3.17 ± 0.33 | 3.63 ± 0.29 |
GTE 80 µg/ml + CTN | 1.30 ± 0.02 | 0.087 ± 0.01# | 4.05 ± 0.38# | 5.04 ± 0.39# |
Cells were pre-incubated with GTE (20, 40, 80 µg/ml) for 2 h, followed by CTN treatment (100 µM) for 24 h. Data are expressed as the mean ± standard deviation from three independent experiments, each performed in triplicate
* p < 0.05 versus control cells, # p < 0.05 versus CTN treated cells